Latest / Raleigh News Today | 2 Min News | The Daily News Now!
Tempus Buys Personalis for MRD Edge | Raleigh News
Tempus AI just dropped a blockbuster: it’s buying Personalis for $1.5 billion, snapping up a revolutionary cancer test that spots hidden disease before scans ever catch it. The NeXT Personal test, which detects minimal residual disease using tumor DNA fragments, has been a joint effort for three years — now Tempus gets full control and all the revenue. With a $20 billion market and only 10% of eligible patients tested, this is a massive play. Personalis is already booming — $22.4M in Q2 revenue and 33% test volume growth. Beyond the test, Tempus grabs Personalis’s genomic data, fueling big…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.